Annual Short Term Debt
$1.30 M
+$1.24 M+2058.14%
31 December 2023
Summary:
Qualigen Therapeutics annual short term debt is currently $1.30 million, with the most recent change of +$1.24 million (+2058.14%) on 31 December 2023. During the last 3 years, it has risen by +$1.17 million (+868.83%). QLGN annual short term debt is now -32.10% below its all-time high of $1.91 million, reached on 31 March 2020.QLGN Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$1.43 M
-$235.80 K-14.12%
30 September 2024
Summary:
Qualigen Therapeutics quarterly short term debt is currently $1.43 million, with the most recent change of -$235.80 thousand (-14.12%) on 30 September 2024. Over the past year, it has increased by +$135.00 thousand (+10.39%). QLGN quarterly short term debt is now -29.51% below its all-time high of $2.03 million, reached on 30 June 2023.QLGN Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +10.4% |
| 3 y3 years | +868.8% | +969.5% |
| 5 y5 years | - | - |
QLGN Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2058.1% | -29.5% | +2282.4% |
| 5 y | 5 years | -32.1% | +2058.1% | -29.5% | +2282.4% |
| alltime | all time | -32.1% | +2058.1% | -29.5% | +2282.4% |
Qualigen Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.43 M(-14.1%) |
| June 2024 | - | $1.67 M(+63.3%) |
| Mar 2024 | - | $1.02 M(-21.3%) |
| Dec 2023 | $1.30 M(+2058.1%) | $1.30 M(+56.1%) |
| Sept 2023 | - | $832.10 K(-59.1%) |
| June 2023 | - | $2.03 M(+15.2%) |
| Mar 2023 | - | $1.77 M(+2833.6%) |
| Dec 2022 | $60.20 K | $60.20 K(-94.7%) |
| Sept 2022 | - | $1.14 M(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $1.12 M(+618.6%) |
| Mar 2022 | - | $155.50 K(+16.0%) |
| Dec 2021 | $134.10 K(-65.3%) | $134.10 K(-51.9%) |
| Sept 2021 | - | $278.90 K(+3.1%) |
| June 2021 | - | $270.60 K(-1.0%) |
| Mar 2021 | - | $273.30 K(-73.6%) |
| Dec 2020 | $386.50 K(-79.8%) | - |
| Sept 2020 | - | $1.03 M(-23.1%) |
| June 2020 | - | $1.35 M |
| Mar 2020 | $1.91 M | - |
FAQ
- What is Qualigen Therapeutics annual short term debt?
- What is the all time high annual short term debt for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly short term debt year-on-year change?
What is Qualigen Therapeutics annual short term debt?
The current annual short term debt of QLGN is $1.30 M
What is the all time high annual short term debt for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual short term debt is $1.91 M
What is Qualigen Therapeutics quarterly short term debt?
The current quarterly short term debt of QLGN is $1.43 M
What is the all time high quarterly short term debt for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly short term debt is $2.03 M
What is Qualigen Therapeutics quarterly short term debt year-on-year change?
Over the past year, QLGN quarterly short term debt has changed by +$135.00 K (+10.39%)